100277
金刚烷
≥99%
别名:
Tricyclo[3.3.1.13,7]decane
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C10H16
化学文摘社编号:
分子量:
136.23
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
206-001-4
Beilstein/REAXYS Number:
1901173
MDL number:
Assay:
≥99%
Form:
solid
Quality Level
assay
≥99%
form
solid
mp
209-212 °C (subl.) (lit.)
SMILES string
C1[C@H]2C[C@H]3C[C@@H]1C[C@@H](C2)C3
InChI
1S/C10H16/c1-7-2-9-4-8(1)5-10(3-7)6-9/h7-10H,1-6H2/t7-,8+,9-,10+
InChI key
ORILYTVJVMAKLC-YNFQOJQRSA-N
Application
金刚烷是金刚烷胺、美金刚、沙格列汀和维格列汀等多种药物重要化合物的结构骨架。 用于合成类卡宾反应的基于金刚烷的四羧酸二铑催化剂。也可作为纳米金刚石薄膜成核的种子材料。
Ayako Takahashi et al.
American journal of physiology. Heart and circulatory physiology, 304(10), H1361-H1369 (2013-03-19)
Incretin hormones, including glucagon-like peptide-1 (GLP-1), a target for diabetes mellitus (DM) treatment, are associated with cardioprotection. As dipeptidyl-peptidase IV (DPP-IV) inhibition increases plasma GLP-1 levels in vivo, we investigated the cardioprotective effects of the DPP-IV inhibitor vildagliptin in a
Benjamin M Scirica et al.
The New England journal of medicine, 369(14), 1317-1326 (2013-09-03)
The cardiovascular safety and efficacy of many current antihyperglycemic agents, including saxagliptin, a dipeptidyl peptidase 4 (DPP-4) inhibitor, are unclear. We randomly assigned 16,492 patients with type 2 diabetes who had a history of, or were at risk for, cardiovascular
Nucleation enhancement of nanocrystalline diamond growth at low substrate temperatures by adamantane seeding.
Tsugawa K, et al.
The Journal of Physical Chemistry C, 114(9), 3822-3824 (2010)
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 100277-25G | 04061838661845 |
| 100277-100G | 04061838661838 |